{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:29:12Z","timestamp":1786400952492,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"33","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special","doi-asserted-by":"publisher","award":["No. 2024-1-5042"],"award-info":[{"award-number":["No. 2024-1-5042"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.1038\/s41388-026-03892-9","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:12:43Z","timestamp":1783703563000},"page":"3456-3471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NME3 promotes clear cell renal cell carcinoma progression and modulates TKI response through MFN1\/2-dependent mitochondrial fusion and mitophagy suppression"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2844-0862","authenticated-orcid":false,"given":"Senming","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9599-9971","authenticated-orcid":false,"given":"Changwei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5327-1668","authenticated-orcid":false,"given":"Jichen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4708-5748","authenticated-orcid":false,"given":"Xing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8257-4670","authenticated-orcid":false,"given":"Xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2931-8699","authenticated-orcid":false,"given":"Wenmei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"3892_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","volume":"87","author":"A Bex","year":"2025","unstructured":"Bex A, Ghanem YA, Albiges L, Bonn S, Campi R, Capitanio U, et al. European association of urology guidelines on renal cell carcinoma: the 2025 update. Eur Urol. 2025;87:683\u201396.","journal-title":"Eur Urol"},{"key":"3892_CR2","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499:43\u201349.","DOI":"10.1038\/nature12222"},{"key":"3892_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.hoc.2023.04.011","volume":"37","author":"NH Shirole","year":"2023","unstructured":"Shirole NH, Kaelin WG Jr. von-Hippel Lindau and hypoxia-inducible factor at the center of renal cell carcinoma biology. Hematol Oncol Clin North Am. 2023;37:809\u201325.","journal-title":"Hematol Oncol Clin North Am"},{"key":"3892_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00441-018-2801-6","volume":"372","author":"K Kluckova","year":"2018","unstructured":"Kluckova K, Tennant DA. Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma. Cell Tissue Res. 2018;372:367\u201378.","journal-title":"Cell Tissue Res"},{"key":"3892_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ctrv.2015.07.002","volume":"41","author":"F Massari","year":"2015","unstructured":"Massari F, Ciccarese C, Santoni M, Brunelli M, Piva F, Modena A, et al. Metabolic alterations in renal cell carcinoma. Cancer Treat Rev. 2015;41:767\u201376.","journal-title":"Cancer Treat Rev"},{"key":"3892_CR6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molcel.2016.02.011","volume":"61","author":"WX Zong","year":"2016","unstructured":"Zong WX, Rabinowitz JD, White E. Mitochondria and cancer. Mol Cell. 2016;61:667\u201376.","journal-title":"Mol Cell"},{"key":"3892_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature12985","volume":"505","author":"JR Friedman","year":"2014","unstructured":"Friedman JR, Nunnari J. Mitochondrial form and function. Nature. 2014;505:335\u201343.","journal-title":"Nature."},{"key":"3892_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tcb.2007.08.006","volume":"17","author":"KL Cerveny","year":"2007","unstructured":"Cerveny KL, Tamura Y, Zhang Z, Jensen RE, Sesaki H. Regulation of mitochondrial fusion and division. Trends Cell Biol. 2007;17:563\u20139.","journal-title":"Trends Cell Biol"},{"key":"3892_CR9","doi-asserted-by":"publisher","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","volume":"28","author":"S Pickles","year":"2018","unstructured":"Pickles S, Vigi\u00e9 P, Youle RJ. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr Biol. 2018;28:R170\u2013R185.","journal-title":"Curr Biol"},{"key":"3892_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","volume":"15","author":"DC Chan","year":"2020","unstructured":"Chan DC. Mitochondrial dynamics and its involvement in disease. Annu Rev Pathol. 2020;15:235\u201359.","journal-title":"Annu Rev Pathol"},{"key":"3892_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","volume":"8","author":"W Chen","year":"2023","unstructured":"Chen W, Zhao H, Li Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct Target Ther. 2023;8:333.","journal-title":"Signal Transduct Target Ther"},{"key":"3892_CR12","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.1038\/onc.2012.500","volume":"32","author":"J Hagenbuchner","year":"2013","unstructured":"Hagenbuchner J, Kuznetsov AV, Obexer P, Ausserlechner MJ. BIRC5\/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion\/fission machinery. Oncogene. 2013;32:4748\u201357.","journal-title":"Oncogene."},{"key":"3892_CR13","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1038\/s41416-024-02670-2","volume":"130","author":"Z Wang","year":"2024","unstructured":"Wang Z, Tang S, Cai L, Wang Q, Pan D, Dong Y, et al. DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma. Br J Cancer. 2024;130:1744\u201357.","journal-title":"Br J Cancer"},{"key":"3892_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/labinvest.2017.137","volume":"98","author":"M Boissan","year":"2018","unstructured":"Boissan M, Schlattner U, Lacombe ML. The NDPK\/NME superfamily: state of the art. Lab Invest. 2018;98:164\u201374.","journal-title":"Lab Invest"},{"key":"3892_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/labinvest.2017.109","volume":"98","author":"GS Puts","year":"2018","unstructured":"Puts GS, Leonard MK, Pamidimukkala NV, Snyder DE, Kaetzel DM. Nuclear functions of NME proteins. Lab Invest. 2018;98:211\u20138.","journal-title":"Lab Invest"},{"key":"3892_CR16","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s10555-023-10118-x","volume":"42","author":"C Prunier","year":"2023","unstructured":"Prunier C, Chavrier P, Boissan M. Mechanisms of action of NME metastasis suppressors - a family affair. Cancer Metastasis Rev. 2023;42:1155\u201367.","journal-title":"Cancer Metastasis Rev"},{"key":"3892_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1073\/pnas.1818629116","volume":"116","author":"CW Chen","year":"2019","unstructured":"Chen CW, Wang HL, Huang CW, Huang CY, Lim WK, Tu IC, et al. Two separate functions of NME3 critical for cell survival underlie a neurodegenerative disorder. Proc Natl Acad Sci USA. 2019;116:566\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3892_CR18","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1158\/0008-5472.CAN-10-1887","volume":"70","author":"M Boissan","year":"2010","unstructured":"Boissan M, De Wever O, Lizarraga F, Wendum D, Poincloux R, Chignard N, et al. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Cancer Res. 2010;70:7710\u201322.","journal-title":"Cancer Res"},{"key":"3892_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nbt.4115","volume":"36","author":"X Huang","year":"2018","unstructured":"Huang X, Fan J, Li L, Liu H, Wu R, Wu Y, et al. Fast, long-term, super-resolution imaging with Hessian structured illumination microscopy. Nat Biotechnol. 2018;36:451\u20139.","journal-title":"Nat Biotechnol"},{"key":"3892_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.tcb.2020.09.008","volume":"31","author":"S Gao","year":"2021","unstructured":"Gao S, Hu J. Mitochondrial fusion: the machineries in and out. Trends Cell Biol. 2021;31:62\u201374.","journal-title":"Trends Cell Biol"},{"key":"3892_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41580-020-0210-7","volume":"21","author":"M Giacomello","year":"2020","unstructured":"Giacomello M, Pyakurel A, Glytsou C, Scorrano L. The cell biology of mitochondrial membrane dynamics. Nat Rev Mol Cell Biol. 2020;21:204\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3892_CR22","doi-asserted-by":"publisher","first-page":"e202301091","DOI":"10.1083\/jcb.202301091","volume":"222","author":"YA Su","year":"2023","unstructured":"Su YA, Chiu HY, Chang YC, Sung CJ, Chen CW, Tei R, et al. NME3 binds to phosphatidic acid and mediates PLD6-induced mitochondrial tethering. J Cell Biol. 2023;222:e202301091.","journal-title":"J Cell Biol"},{"key":"3892_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1083\/jcb.201609019","volume":"215","author":"Y Qi","year":"2016","unstructured":"Qi Y, Yan L, Yu C, Guo X, Zhou X, Hu X, et al. Structures of human mitofusin 1 provide insight into mitochondrial tethering. J Cell Biol. 2016;215:621\u20139.","journal-title":"J Cell Biol"},{"key":"3892_CR24","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1046\/j.1432-1327.2001.2076.doc.x","volume":"268","author":"M Erent","year":"2001","unstructured":"Erent M, Gonin P, Cherfils J, Tissier P, Raschell\u00e0 G, Giartosio A, et al. Structural and catalytic properties and homology modelling of the human nucleoside diphosphate kinase C, product of the DRnm23 gene. Eur J Biochem. 2001;268:1972\u201381.","journal-title":"Eur J Biochem"},{"key":"3892_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/14737140.2019.1559058","volume":"19","author":"B Escudier","year":"2019","unstructured":"Escudier B, Worden F, Kudo M. Sorafenib: key lessons from over 10 years of experience. Expert Rev Anticancer Ther. 2019;19:177\u201389.","journal-title":"Expert Rev Anticancer Ther"},{"key":"3892_CR26","doi-asserted-by":"publisher","first-page":"15105","DOI":"10.1074\/jbc.M117.783175","volume":"292","author":"C Zhang","year":"2017","unstructured":"Zhang C, Liu Z, Bunker E, Ramirez A, Lee S, Peng Y, et al. Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1-Parkin pathway and modulate cellular drug response. J Biol Chem. 2017;292:15105\u201320.","journal-title":"J Biol Chem"},{"key":"3892_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","volume":"5","author":"W Tang","year":"2020","unstructured":"Tang W, Chen Z, Zhang W, Cheng Y, Zhang B, Wu F, et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020;5:87.","journal-title":"Signal Transduct Target Ther"},{"key":"3892_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-021-00594-4","volume":"6","author":"J Xu","year":"2021","unstructured":"Xu J, Ji L, Ruan Y, Wan Z, Lin Z, Xia S, et al. UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1\u03b2 in hepatocellular carcinoma. Signal Transduct Target Ther. 2021;6:190.","journal-title":"Signal Transduct Target Ther"},{"key":"3892_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11010-009-0120-7","volume":"329","author":"M Boissan","year":"2009","unstructured":"Boissan M, Dabernat S, Peuchant E, Schlattner U, Lascu I, Lacombe ML. The mammalian Nm23\/NDPK family: from metastasis control to cilia movement. Mol Cell Biochem. 2009;329:51\u201362.","journal-title":"Mol Cell Biochem"},{"key":"3892_CR30","doi-asserted-by":"publisher","first-page":"11751","DOI":"10.1158\/0008-5472.CAN-07-3175","volume":"67","author":"CE Horak","year":"2007","unstructured":"Horak CE, Mendoza A, Vega-Valle E, Albaugh M, Graff-Cherry C, McDermott WG, et al. Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2. Cancer Res. 2007;67:11751\u20139.","journal-title":"Cancer Res"},{"key":"3892_CR31","doi-asserted-by":"publisher","first-page":"5006","DOI":"10.1158\/1078-0432.CCR-08-0238","volume":"14","author":"PS Steeg","year":"2008","unstructured":"Steeg PS, Horak CE, Miller KD. Clinical-translational approaches to the Nm23-H1 metastasis suppressor. Clin Cancer Res. 2008;14:5006\u201312.","journal-title":"Clin Cancer Res"},{"key":"3892_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10585-012-9495-z","volume":"30","author":"SG Jarrett","year":"2013","unstructured":"Jarrett SG, Novak M, Harris N, Merlino G, Slominski A, Kaetzel DM. NM23 deficiency promotes metastasis in a UV radiation-induced mouse model of human melanoma. Clin Exp Metastasis. 2013;30:25\u201336.","journal-title":"Clin Exp Metastasis"},{"key":"3892_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04234-1","volume":"12","author":"Y Qi","year":"2021","unstructured":"Qi Y, Wei J, Zhang X. Requirement of transcription factor NME2 for the maintenance of the stemness of gastric cancer stem-like cells. Cell Death Dis. 2021;12:924.","journal-title":"Cell Death Dis"},{"key":"3892_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1158\/0008-5472.CAN-21-1020","volume":"82","author":"X Ren","year":"2022","unstructured":"Ren X, Rong Z, Liu X, Gao J, Xu X, Zi Y, et al. The protein kinase activity of NME7 activates Wnt\/\u03b2-catenin signaling to promote one-carbon metabolism in hepatocellular carcinoma. Cancer Res. 2022;82:60\u201374.","journal-title":"Cancer Res"},{"key":"3892_CR35","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1126\/science.1219855","volume":"337","author":"RJ Youle","year":"2012","unstructured":"Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science. 2012;337:1062\u20135.","journal-title":"Science."},{"key":"3892_CR36","doi-asserted-by":"publisher","first-page":"115342","DOI":"10.1016\/j.biopha.2023.115342","volume":"166","author":"Y Guo","year":"2023","unstructured":"Guo Y, Luo C, Sun Y, Guo W, Zhang R, Zhang X, et al. Inhibition of mitochondrial fusion via SIRT1\/PDK2\/PARL axis breaks mitochondrial metabolic plasticity and sensitizes cancer cells to glucose restriction therapy. Biomed Pharmacother. 2023;166:115342.","journal-title":"Biomed Pharmacother"},{"key":"3892_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05721-3","volume":"14","author":"P Chen","year":"2023","unstructured":"Chen P, Lu Y, He B, Xie T, Yan C, Liu T, et al. Rab32 promotes glioblastoma migration and invasion via regulation of ERK\/Drp1-mediated mitochondrial fission. Cell Death Dis. 2023;14:198.","journal-title":"Cell Death Dis"},{"key":"3892_CR38","doi-asserted-by":"publisher","first-page":"e158429","DOI":"10.1172\/jci.insight.158429","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu Z, Lei J, Wu T, Hu W, Zheng M, Wang Y, et al. Lipogenesis promotes mitochondrial fusion and maintains cancer stemness in human NSCLC. JCI Insight. 2023;8:e158429.","journal-title":"JCI Insight"},{"key":"3892_CR39","doi-asserted-by":"publisher","first-page":"nwae039","DOI":"10.1093\/nsr\/nwae039","volume":"11","author":"J Zhou","year":"2024","unstructured":"Zhou J, Zhang H, Zhong K, Tao L, Lin Y, Xie G, et al. N6-methyladenosine facilitates mitochondrial fusion of colorectal cancer cells via induction of GSH synthesis and stabilization of OPA1 mRNA. Natl Sci Rev. 2024;11:nwae039.","journal-title":"Natl Sci Rev"},{"key":"3892_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1101\/sqb.2012.76.011015","volume":"76","author":"R Mathew","year":"2011","unstructured":"Mathew R, White E. Autophagy, stress, and cancer metabolism: what doesn\u2019t kill you makes you stronger. Cold Spring Harb Symp Quant Biol. 2011;76:389\u201396.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"3892_CR41","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1007\/s00018-021-03774-1","volume":"78","author":"LP Poole","year":"2021","unstructured":"Poole LP, Macleod KF. Mitophagy in tumorigenesis and metastasis. Cell Mol Life Sci. 2021;78:3817\u201351.","journal-title":"Cell Mol Life Sci"},{"key":"3892_CR42","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24:560\u201375.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3892_CR43","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1111\/jcmm.17813","volume":"27","author":"T Liu","year":"2023","unstructured":"Liu T, Zhu H, Ge M, Pan Z, Zeng Y, Leng Y, et al. GPD1L inhibits renal cell carcinoma progression by regulating PINK1\/Parkin-mediated mitophagy. J Cell Mol Med. 2023;27:2328\u201339.","journal-title":"J Cell Mol Med"},{"key":"3892_CR44","doi-asserted-by":"publisher","first-page":"112737","DOI":"10.1016\/j.intimp.2024.112737","volume":"140","author":"J Guo","year":"2024","unstructured":"Guo J, Chen Q, Han S, Wang T, Xia K, Yu B, et al. Construction of an autophagy-related genes risk model as predicting prognosis: BAG1 suppresses growth of clear cell renal cell carcinoma. Int Immunopharmacol. 2024;140:112737.","journal-title":"Int Immunopharmacol"},{"key":"3892_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07476-5","volume":"16","author":"M Kim","year":"2025","unstructured":"Kim M, Hong WC, Kang HW, Kim JH, Lee D, Cheong JH, et al. SLC5A3 depletion promotes apoptosis by inducing mitochondrial dysfunction and mitophagy in gemcitabine-resistant pancreatic cancer cells. Cell Death Dis. 2025;16:161.","journal-title":"Cell Death Dis"},{"key":"3892_CR46","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41392-022-01253-y","volume":"7","author":"Y Meng","year":"2022","unstructured":"Meng Y, Qiu L, Zeng X, Hu X, Zhang Y, Wan X, et al. Targeting CRL4 suppresses chemoresistant ovarian cancer growth by inducing mitophagy. Signal Transduct Target Ther. 2022;7:388.","journal-title":"Signal Transduct Target Ther"},{"key":"3892_CR47","first-page":"e135438","volume":"6","author":"WJ Wang","year":"2021","unstructured":"Wang WJ, Lai HY, Zhang F, Shen WJ, Chu PY, Liang HY, et al. MCL1 participates in leptin-promoted mitochondrial fusion and contributes to drug resistance in gallbladder cancer. JCI Insight. 2021;6:e135438.","journal-title":"JCI Insight"},{"key":"3892_CR48","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.jhep.2025.03.028","volume":"83","author":"GY Lv","year":"2025","unstructured":"Lv GY, Mu WT, Cao YN, Sun XD, Wei F, Chai KY, et al. Cisplatin-induced disruption of mitochondrial divisome leads to enhanced cisplatin resistance in cholangiocarcinoma. J Hepatol. 2025;83:917\u201330.","journal-title":"J Hepatol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03892-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03892-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03892-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:02:49Z","timestamp":1786399369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03892-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":48,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2026,9,1]]}},"alternative-id":["3892"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03892-9","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Human tissue samples were obtained from the Department of Urology at the Chinese PLA General Hospital, in compliance with the protocol approved by the hospital\u2019s Ethics Committee. Prior to sample collection, all participants provided written informed consent, and the study adhered to all applicable ethical guidelines for research involving human subjects.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}